EDAP TMS SA (EDAP)
4.10
+0.42
(+11.41%)
USD |
NASDAQ |
Jan 12, 16:00
4.09
-0.01
(-0.24%)
After-Hours: 20:00
EDAP TMS Research and Development Expense (Quarterly): 2.438M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| DBV Technologies SA | 26.82M |
| Cellectis SA | 19.34M |
| Genfit SA | -- |
| Ascendis Pharma A/S | 76.00M |
| Akari Therapeutics Plc | 0.2475M |